Dyah Erawati
Department Of Obstetric And Gynecology, Faculty Of Medicine, Universitas Airlangga, Surabaya

Published : 6 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Majalah Obstetri dan Ginekologi

Demografi, Respon Terapi dan Survival rate Pasien Kanker Serviks Stadium III-IVA yang Mendapat Kemoterapi Dilanjutkan Radioterapi Yuski Amin; Pungky Mulawardhana; Dyah Erawati
Majalah Obstetri dan Ginekologi Vol. 23 No. 3 (2015): September - Desember 2015
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (132.506 KB) | DOI: 10.20473/mog.V23I32015.97-105

Abstract

 Tujuan: Mengetahui demografi pasien kanker serviks III-IVa, respon terapi dan survival rate pasien kanker serviks stadium III-IVA yang mendapat kemoterapi dilanjutkan radioterapi di RSUD Dr. Soetomo Surabaya tahun 2011-2013.Bahan dan Metode: Penelitian ini adalah penelitian deskriptif rektrospektif dengan menggunakan rekam medis Poli Onkologi Kandungan dan SMF/Instalasi Radioterapi RSUD Dr.Soetomo. Subyek penelitian adalah pasien kanker serviks III-IVA yang mendapat kemoterapi dilanjutkan radioterapi mulai Januari 2011 sampai Desember 2013. Analisis statistika pada penelitian ini menggunakan analisis deskriptif dan analisis survival meng-gunakan metode Kaplan Meier.Hasil: Selama tahun 2011-2013 didapatkan kunjungan pasien baru kanker serviks III-IVA sebanyak 648 pasien. Jumlah pasien kanker serviks IIIA sebanyak 48 kasus, stadium IIIB sebanyak 594 kasus dan stadium IVA sebanyak 6 kasus. Jumlah pasien kanker serviks III–IVA yang mendapat kemoterapi dilanjutkan radioterapi selama tahun 2011-2013 sebanyak 77 pasien. Pasien kanker serviks stadium IIIA sebanyak 8 pasien, stadium IIIB sebanyak 69 pasien. Tidak ada pasien kanker serviks stadium IVA yang mendapat kemoterapi dilanjutkan radioterapi. Respon terapi komplet sebesar 88,3% dan respon terapi inkomplet sebesar 11,7%. Analisis survival dengan metode Kaplan-Meier didapatkan 2-YSR dan 3-YSR kanker serviks stadium IIIA sebesar 86% dan 34%. Pada stadium IIIB didapatkan 2-YSR dan 3-YSR sebesar 47% dan 25%.Median survival pada semua kelompok pada penelitian ini adalah 25 bulan.Simpulan: Jumlah pasien kanker serviks III-IVA yang mendapat kemoterapi dilanjutkan radioterapi selama tahun 2011-2013 sebanyak 77 pasien. Respon terapi komplet pasca radioterapi sebesar 88,3% dan respon terapi inkomplet sebesar 11,7%. Hasil analisis survival didapatkan 2-YSR dan 3-YSR kanker serviks stadium IIIA sebesar 86% dan 34%. Pada stadium IIIB didapatkan 2-YSR dan 3-YSR sebesar 47% dan 25%. 
Diagnostic value of abdominal CT scan in ovarian tumors in Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, from January 2017 to December 2018 Ida Bagus Gede Ramayuda; Lies Mardiyana; Dyah Erawati; Indra Yuliati
Majalah Obstetri dan Ginekologi Vol. 29 No. 2 (2021): August
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/mog.V29I22021.45-52

Abstract

HIGHLIGHTS1. Ovarian tumors diagnostic value has been determined using the tools on contrast-enhanced abdominal CT Scan.2. The tools including primary finding like mass size, septation, solid component, and additional finding such as ascites, peritoneal implants, lymph node enlargement.3. Most tumors were ovarian malignant tumors according to their histopathological results.4. Contrast-enhanced abdominal CT Scan of ovarian tumors evaluated by the tools gave better and more reliable diagnostic value than without using the tools.ABSTRACTObjectives: The purpose of this study was to determine the diagnostic value of contrast-enhanced abdominal CT scan in ovarian tumors in Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, to provide scientific and clinical benefits.Materials and Methods: Samples were taken retrospectively by contrast-enhanced abdominal CT scan raw data in Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, from January 2017 to December 2018. Using inclusion and exclusion criteria, a total of 88 samples were obtained and reviewed blindly by Female Organ Division of Radiology Department, Faculty of Medicine Universitas Airlangga, and by using "tools" (primary and additional findings of modified ovarian tumors malignancy). The data were correlated with histopathological findings and analyzed by statistical tests and the results with and without "tools" were compared.Results: Samples were grouped by age, distributed with a range of 20 years and the group of 41-60 years had the highest age of ovarian tumor samples (46.6%) with 84.1% being ovarian malignant tumors according to their histopathological results. It was dominated by serous, mucinous and endometroid types with sensitivity of 93.3%, specificity of 64.3%, positive predictive value of 93.3% negative predictive value of 69.2%, and accuracy value of 89.8%. More reliable results were obtained by using “tools”.Conclusion: Contrast-enhanced abdominal CT scan of ovarian tumors in Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, evaluated by “tools” still had a better and more reliable diagnostic value than without tools in determining policy steps in handling ovarian tumors with a note that more in-depth research on pitfalls is needed so it may enrich the characteristic findings in imaging.